Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Armand

Showing results (101-110 of 273) with videos related to

Pageof 28
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host diseaseSarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Blood|November 16, 2017
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host diseaseKathy S Wang, Haesook T Kim, Sarah Nikiforow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipientsNicolas C Issa, Francisco M Marty, Lisa S Gagne, et al.
Blood Advances|September 2, 2022
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphomaJeremy S Abramson, Elizabeth Bengston, Robert Redd, et al.
Blood|July 20, 2019
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphomaMatthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, et al.
Blood|April 19, 2014
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationPhilippe Armand, Haesook T Kim, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2016
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for LymphomaNatasha Kekre, Francisco J Marquez-Malaver, Monica Cabrero, et al.
Transplantation and Cellular Therapy|May 4, 2021
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host DiseaseZhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, et al.
Pageof 28

Showing results (101-110 of 273) with videos related to

Sort By:
Pageof 28
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host diseaseSarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Blood|November 16, 2017
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host diseaseKathy S Wang, Haesook T Kim, Sarah Nikiforow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipientsNicolas C Issa, Francisco M Marty, Lisa S Gagne, et al.
Blood Advances|September 2, 2022
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphomaJeremy S Abramson, Elizabeth Bengston, Robert Redd, et al.
Blood|July 20, 2019
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphomaMatthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, et al.
Blood|April 19, 2014
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationPhilippe Armand, Haesook T Kim, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2016
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for LymphomaNatasha Kekre, Francisco J Marquez-Malaver, Monica Cabrero, et al.
Transplantation and Cellular Therapy|May 4, 2021
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host DiseaseZhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, et al.
Pageof 28